Myriad Genetics (MYGN) Cash & Equivalents Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -20.26% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 14.02% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 11.37% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | 39.74% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | -14.97% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 70.63% |
| 10 | Myriad Genetics | 295.16 Mn | 170.76 Mn | 137.60 Mn | 32.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.40% |
| Dec 31, 2025 | 38.02% |
| Sep 30, 2025 | 10.18% |
| Jun 30, 2025 | -10.62% |
| Mar 31, 2025 | -17.62% |
| Dec 31, 2024 | -26.45% |
| Sep 30, 2024 | -30.31% |
| Jun 30, 2024 | -7.93% |
| Mar 31, 2024 | -13.34% |
| Dec 31, 2023 | 4.13% |
| Sep 30, 2023 | -13.71% |
| Jun 30, 2023 | -14.37% |
| Mar 31, 2023 | -23.77% |
| Dec 31, 2022 | -11.18% |
| Sep 30, 2022 | 6.53% |
| Jun 30, 2022 | 3.79% |
| Mar 31, 2022 | 24.59% |
| Dec 31, 2021 | 41.63% |
| Sep 30, 2021 | 46.81% |
| Jun 30, 2021 | 2.21% |